ImageneBio (IMA) EBT (2020 - 2024)
Historic EBT for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to -$17.3 million.
- ImageneBio's EBT rose 1183.15% to -$17.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$50.3 million, marking a year-over-year increase of 2639.04%. This contributed to the annual value of -$49.1 million for FY2024, which is 2816.71% up from last year.
- Per ImageneBio's latest filing, its EBT stood at -$17.3 million for Q4 2024, which was up 1183.15% from -$3.2 million recorded in Q3 2024.
- In the past 5 years, ImageneBio's EBT registered a high of $2.8 million during Q4 2021, and its lowest value of -$26.1 million during Q4 2020.
- Moreover, its 5-year median value for EBT was -$14.4 million (2021), whereas its average is -$13.3 million.
- Its EBT has fluctuated over the past 5 years, first surged by 11073.58% in 2021, then plummeted by 60400.43% in 2022.
- Over the past 5 years, ImageneBio's EBT (Quarter) stood at -$26.1 million in 2020, then surged by 110.74% to $2.8 million in 2021, then tumbled by 604.0% to -$14.1 million in 2022, then plummeted by 39.4% to -$19.7 million in 2023, then increased by 11.83% to -$17.3 million in 2024.
- Its last three reported values are -$17.3 million in Q4 2024, -$3.2 million for Q3 2024, and -$13.7 million during Q2 2024.